The evaluation of serum levels of LH and FSH in combination with testosterone provides important information to pinpoint the localization of hypogonad-ism, which is then decisive for adequate therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, Ivell R (2006) Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 29:618–626
Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241–4247
Ballescá JL, Balasch J, Calafell JM, Alvarez R, Fábregues F, de Osaba MJ, Ascaso C, Vanrell JA (2000) Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod 15:1734–1738
Bay K, Virtanen HE, Hartung S, Ivell R, Main KM, Skakkebaek NE, Andersson AM, Nordic Cryptorchidism Study Group, Toppari J (2007) Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypotha-lamic-pituitary-gonadal axis activation, and cryptorchidism. J Clin Endocrinol Metab 92:4020–4027
Bergmann M, Behre HM, Nieschlag E (1994) Serum FSH and testicular morphology in male infertility. Clin Endocrinol 40:133–136
Bhagavath B, Layman LC (2007) The genetics of hypogonado-tropic hypogonadism. Semin Reprod Med 25:272–286
Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombès M, Millar RP, Guiochon-Mantel A, Young J (2009) Isolated familial hypogonadotropic hypogo-nadism and a GnRH1 mutation. N Engl J Med 360: 2742–2748
Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 58:710–717
Foresta C, Zuccarello D, Garolla A, Ferlin A (2008) Role of hormones, genes and environment in human cryptorchidism. Endocr Rev 29:560–580
Goldstein M, Tanrikut C (2006) Microsurgical management of male infertility. Nat Clin Pract Urol 3:381–391
Goulis DG, Tsametis C, Iliadou PK, Polychronou P, Kantartzi PD, Tarlatzis BC, Bontis IN, Papadimas I (2009) Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoo-spermia. Fertil Steril 91:1279–1284
Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB (2004) The “trouble” with salivary testosterone. Psychoneu-roendocrinology 29:1229–1240
Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F (1999) Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine 78:236–269
Huhtaniemi I, Alevizaki M (2006) Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 20:561–576
Huhtaniemi I, Themmen AP (2005) Mutations in human gonad-otropin and gonadotropin-receptor genes. Endocrine 26: 207–217
Josso N, Picard J Y, Rey R, di Clemente N (2006) Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3:347–358
Kelleher S, Conway AJ, Handelsman DJ (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89:3813–3817
Le Moli R, Endert E, Fliers E, Prummel MF, Wiersinga WM (2003) Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Neth J Med 61:44–48
Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT (1997) Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 336:1480–1486
Licea-Perez H, Wang S, Szapacs ME, Yang E (2008) Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5α-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism. Steroids 73:601–610
Meachem SJ, Nieschlag E, Simoni M (2001) Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 145:561–571
Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC (2004) Testosterone replacement therapy: current trends and future directions. Hum Rreprod Update 10:409–419
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 3: 125–127
O'Connor AE, De Kretser DM (2004) Inhibins in normal male physiology. Semin Reprod Med 22:177–185
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405–413
Roy P, Alevizaki M, Huhtaniemi I (2008) In vitro bioassays for androgens and their diagnostic applications. Hum Reprod Update 14:73–82
Schürmeyer T, Jung K, Nieschlag E (1984) The effect of an 1100 km run on testicular, adrenal and thyroid hormones. Int J Androl 7:276–282
Sequera AM, Fideleff HL, Boquete HR, Pujol AB, Suárez MG, Ruibal GF (2002) Basal ultrasensitive LH assay: a useful tool in the early diagnosis of male pubertal delay? J Pediatr Endocrinol Metab 15:589–596
Simoni M (2004) Methodology for measuring testosterone, DHT and SHBG in a clinical setting. In: Nieschlag E, Behre HM (eds) Testosterone action, deficiency, substitution, 3rd edn. Cambridge University Press, Cambridge, pp 641–664
Simoni M, Nieschlag E (1991) In vitro bioassays of follicle-stimulating hormone: methods and clinical applications. J Endocrinol Invest 14:983–997
Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773
Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G (2008) Seminal anti-mullerian hormone level is a marker of sper-matogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod 23:1029–1034
Smith TP, Kavanagh L, Healy ML, McKenna TJ (2007) Technology insight: measuring prolactin in clinical samples. Nat Clin Pract Endocrinol Metab 3:279–289
Stroud MA, Ritz P, Coward PA, Sawyer MB, Constantin-Teodosiu D, Greenhaff PL, Macdonald IA (1997) Energy expenditure using isotope-labelled water (2H218O), exercise performance, skeletal muscle enzyme activities and plasma biochemical parameters in humans during 95 days of enducrance exercise with inadequate energy intake. Eur J Appl Physiol Occup Physiol 76:243–252
Sussman EM, Chudnovsky A, Niederberger CS (2008) Hormonal evaluation of the infertile male: has it evolved? Urol Clin North Am 35:147–155
Tüttelmann F, Dykstra N, Themmen AP, Visser JA, Nieschlag E, Simoni M (2009) Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with malde-scended testes. Fertil Steril 91:1812–1819
Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672
von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, Nieschlag E (1999) Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 84:2496–2501
Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2009) Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl 32:1–10
Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D (2008) European male aging study group. J Clin Endocrinol Metab 93:2737–2745
Zitzmann M, Nieschlag E (2001) Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 144:183–197
Zitzmann M, Nieschlag E (2003) Hypogonadism in the elderly men. Reliable diagnosis and therapy. Internist 44:1313–1321
Zitzmann M, Faber S, Nieschlag E (2006a) Association of spe-cific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335–4343
Zitzmann M, Nordhoff V, von Schönfeldt V, Nordsiek-Mengede A, Kliesch S, Schüring AN, Luetjens CM, Kamischke A, Cooper T, Simoni M, Nieschlag E (2006b) Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril 86:339–347
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Simoni, M., Nieschlag, E. (2010). Endocrine Laboratory Diagnosis. In: Nieschlag, E., Behre, H.M., Nieschlag, S. (eds) Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78355-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-78355-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78354-1
Online ISBN: 978-3-540-78355-8
eBook Packages: MedicineMedicine (R0)